SURMODICS INC (SRDX) - Insider Holders & Insider Ownership

List of insiders holdings for SURMODICS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Ramius LLC
C4S & CO LLC
COHEN PETER A
STARK MORGAN B
STRAUSS THOMAS W
SOLOMON JEFFREY M
COWEN GROUP INC.
RCG HOLDINGS LLC
10% Owner		2011-01-06 17:17:192,088,760
0		2,088,760Form 13D
2Ramius LLC
RAMIUS ADVISORS LLC
RAMIUS VALUE & OPPORTUNITY MASTER FUND LTD
Ramius Value & Opportunity Advisors LLC
Cowen Overseas Investment LP
10% Owner		2011-01-06 17:17:192,088,760
0		2,088,760Form 13D
3OLSETH DALE R
Director		2011-02-11 14:01:47760,619
0		760,619Form 13G
4GUIRE PATRICK E
Senior Vice President		2004-11-12 12:40:49242,329
132,490		374,819Form 5
5KOCH DAVID A
Director		2009-01-20 14:38:03325,003
0		325,003Form 13G
6VERSEN MARIE J
VP Qual Mgmt & Reg Compliance		2005-02-02 14:45:5190,514
0		90,514Form 4
7MILLER LOREN R
Vice President and Controller		2007-08-15 14:33:3962,369
0		62,369Form 4
8ANKENY PHILIP D
Interim CEO, Senior VP & CFO		2010-12-02 18:17:0561,983
0		61,983Form 4
9BARCLAY BRUCE
President & CEO		2010-02-10 12:54:2956,880
0		56,880Form 4
10Wood David S
VP & GM - Drug Del. Bus. Unit		2006-03-22 16:56:0356,808
0		56,808Form 4
11OFSTEAD RONALD F
VP Chemistry Development		2004-01-29 16:33:5951,910
0		51,910Form 4
12YUNG GREGORY T
VP Sales & Marketing		2005-02-02 14:08:2250,415
0		50,415Form 4
13Greaney Thomas A.
COO of Medical Devices		2019-11-27 15:25:3345,681
0		45,681Form 4
14CARLSON RICHARD C
VP of Strategic Planning		2004-02-04 13:51:0144,752
0		44,752Form 4
15KALICH RONALD B SR
Director		2024-02-12 16:12:4642,131
0		42,131Form 4
16LaFrence Andrew D. C.
VP of Finance & CFO		2017-11-30 20:24:5941,771
0		41,771Form 4
17Starboard Value LP
Starboard Value GP LLC
Starboard Principal Co LP
Starboard Principal Co GP LLC
Smith Jeffrey C
MITCHELL MARK R
Feld Peter A
STARBOARD VALUE & OPPORTUNITY MASTER FUND LTD
See Footnote 1.
10% Owner		2012-09-10 17:24:5041,412
0		41,412Form 13D
18Phillips Bryan K
SVP, Gen Counsel & Secretary		2019-12-02 16:10:2035,311
0		35,311Form 4
19TIPTON ARTHUR J
VP, Pres of Pharmaceuticals		2010-12-02 18:36:1430,991
0		30,991Form 4
20Rusch Eugene C.
VP, Manufacturing		2010-12-02 18:31:1727,548
0		27,548Form 4
21Webster Jan M
VP of HR		2010-12-02 18:38:2527,548
0		27,548Form 4
22Sutton Gregg S
VP of Research and Development		2019-12-02 16:11:3825,263
0		25,263Form 4
23FISCHER GERALD B
Director		2014-12-05 15:29:3921,133
0		21,133Form 4
24KEOUGH STEVEN J
Sr VP/Gen Mgr Orth/Chf IP Cnsl		2008-03-25 19:07:4119,943
0		19,943Form 4
25BENSON JOHN W
Director		2015-12-22 17:29:4718,565
0		18,565Form 4
26Lopez Paul A
VP, President - Ophthamology		2010-02-10 13:14:2518,283
0		18,283Form 4
27KELLER KENNETH H
Director		2010-12-02 18:02:5216,528
0		16,528Form 4
28MESLOW JOHN A
Director		2010-12-02 18:07:0616,528
0		16,528Form 4
29Shoup Michael J
VP of Qual, Reg & Clinical		2010-02-10 13:21:2816,251
0		16,251Form 4
30McCormick Shawn
Director		2020-02-18 16:35:5613,428
0		13,428Form 4
31NICHOLS JANE M
Vice President Marketing		2004-01-29 16:33:1912,500
0		12,500Form 4
32DURAN LISE W
VP of Research		2010-02-10 12:59:2812,189
0		12,189Form 4
33Anderson Aron B
VP & Chief Scientific Officer		2010-02-10 12:47:1612,189
0		12,189Form 4
34BUHRMASTER ROBERT C
Director		2014-02-06 17:09:1711,672
0		11,672Form 4
35Robey Brian L
Sr VP, Product Development		2010-05-18 16:27:071,233
9,432		10,665Form 4
36NELSON TIMOTHY S
Director		2014-12-05 15:32:0310,606
0		10,606Form 4
37MELROSE KENDRICK B
Director		2008-11-19 19:19:4910,000
0		10,000Form 4/A
38WARD SCOTT R
Director		2014-12-05 15:32:449,783
0		9,783Form 4
39ASTRY DOUGLAS P
Gen Mgr, In Vitro Technologies		2010-02-10 12:51:598,126
0		8,126Form 4
40Lehman Mark A.
Corporate Controller		2014-11-20 17:20:506,957
0		6,957Form 4
41Sultana Nusrath
VP, Clinical Affairs		2022-02-14 16:41:066,530
0		6,530Form 4
42Ginsberg Peter L
VPof Bus Devlpmt & Strat Plan		2008-05-21 16:35:175,527
0		5,527Form 4
43BRAINERD MARY K
Former Director
Director		2014-05-09 17:40:394,729
0		4,729Form 4
44Seibert Amy E.
Principal Accounting Officer		2016-05-02 15:55:081,645
0		1,645Form 4
45Middleton John C.
VP, Drug Del, Product Dev		2010-08-03 14:19:561,643
0		1,643Form 4
46OLSON CHARLES W
SVP, Medical Device Coatings		2025-11-19 18:18:200
0		0Form 4
47Manders John D.
VP Finance, Corp. Controller		2025-11-19 18:16:530
0		0Form 4
48Weber Gordon S.
Sr. VP of Legal, GC and Sec.		2025-11-19 18:15:410
0		0Form 4
49SIDES TERI WOODWICK
SVP, Vascular Interventions		2025-11-19 18:14:230
0		0Form 4
50DANTZKER DAVID
Director		2025-11-19 18:13:060
0		0Form 4
51Heine Lisa Wipperman
Director		2025-11-19 18:11:460
0		0Form 4
52KNIGHT SUSAN E
Director		2025-11-19 18:10:050
0		0Form 4
53BEDOYA JOSE H
Director		2025-11-19 18:08:320
0		0Form 4
54Arens Timothy J.
Chief Financial Officer		2025-11-19 18:06:260
0		0Form 4
55Stich Joseph J.
SVP of HR, President IVD		2025-11-19 18:04:440
0		0Form 4
56Maharaj Gary R
President & CEO		2025-11-19 18:03:240
0		0Form 4
57Meckler Jeffrey A
See Explanation of Responses		2010-12-03 18:29:070
0		0Form 3